Pubblicazioni

Association Between Active DNA Demethylation and Liver Fibrosis in Individuals with Metabolic-Associated Steatotic Liver Disease (MASLD)

2025 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Barchetta, Ilaria; Zampieri, Michele; Cimini, Flavia Agata; Dule, Sara; Sentinelli, Federica; Passarella, Giulia; Oldani, Alessandro; Karpach, Katsiaryna; Bacalini, Maria Giulia; Baroni, Marco Giorgio; Reale, Anna; Cavallo, Maria Gisella

High-fat diets: You are what you eatâ¦.your extracellular vesicles too!

2024 - JOURNAL OF EXTRACELLULAR VESICLES

Rome, S.; Tacconi, S.

Autophagy and inflammation an intricate affair in the management of obesity and metabolic disorders: evidence for novel pharmacological strategies?

2024 - FRONTIERS IN PHARMACOLOGY

Friuli, Marzia; Sepe, Christian; Panza, Elisabetta; Travelli, Cristina; Paterniti, Irene; Romano, Adele

p16 INK4A drives non-alcoholic fatty liver disease phenotypes in high fat diet fed mice via biliary e2f1/foxo1/igf-1 signaling

2023 - HEPATOLOGY

Kundu, Debjyoti; Kennedy, Lindsey; Zhou, Tianhao; Ekser, Burcin; Meadows, Vik; Sybenga, Amelia; Kyritsi, Konstantina; Chen, Lixian; Ceci, Ludovica; Wu, Nan; Wu, Chaodong; Glaser, Shannon; Carpino, Guido; Onori, Paolo; Gaudio, Eugenio; Alpini, Gianfranco; Francis, Heather

Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication

2023 - METABOLITES

Biagi, Filippo; Carlomagno, Francesco; Carbone, Martina; Veralli, Roberta; Vespasiani-Gentilucci, Umberto; Riva, Elisabetta; Manfrini, Silvia; Tuccinardi, Dario; De Santis, Adriano; Gnessi, Lucio; Watanabe, Mikiko

Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity

2023 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Barchetta, I; Cimini, Fa; Sentinelli, F; Chiappetta, C; Di Cristofano, C; Silecchia, G; Leonetti, F; Baroni, Mg; Cavallo, Mg

MiR-182-5p Is Upregulated in Hepatic Tissues from a Diet-Induced NAFLD/NASH/HCC C57BL/6J Mouse Model and Modulates Cyld and Foxo1 Expression

2023 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Compagnoni, C; Capelli, R; Zelli, V; Corrente, A; Vecchiotti, D; Flati, I; DI VITO NOLFI, M; Angelucci, A; Alesse, E; Zazzeroni, F; Tessitore, A.

Clinical characteristics of metabolic associated fatty liver disease (MAFLD) in subjects with myotonic dystrophy type 1 (DM1)

2021 - DIGESTIVE AND LIVER DISEASE

Miele, L.; Perna, A.; Dajko, M.; Zocco, M. A.; De Magistris, A.; Nicoletti, T. F.; Biolato, M.; Marrone, G.; Liguori, A.; Maccora, D.; Valenza, V.; Rossi, S.; Riso, V.; Di Natale, D.; Gasbarrini, A.; Grieco, A.; Silvestri, G.

Long-term abuse of a high-carbohydrate diet is as harmful as a high-fat diet for development and progression of liver injury in a mouse model of NAFLD/NASH

2020 - NUTRITION

Pompili, S.; Vetuschi, A.; Gaudio, E.; Tessitore, A.; Capelli, R.; Alesse, E.; Latella, G.; Sferra, R.; Onori, P.

Bariatric surgery in the setting of liver cirrhosis with portal hypertension: the confection and particularities of Roux-en-Y gastric bypass in a high-risk patient

2020 - OBESITY SURGERY

Frey, S.; Petrucciani, N.; Iannelli, A.

Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): An update

2020 - NUTRIENTS

Barchetta, I.; Cimini, F. A.; Cavallo, M. G.

Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity

2019 - BMC MEDICINE

Barchetta, Ilaria; EnhÃ¶rning, Sofia; Cimini, Flavia Agata; Capoccia, Danila; Chiappetta, Caterina; Di Cristofano, Claudio; Silecchia, Gianfranco; Leonetti, Frida; Melander, Olle; Cavallo, Maria Gisella

Insulin resistance, but not insulin response, during oral glucose tolerance test (OGTT) is associated to worse histological outcome in obese NAFLD

2019 - NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Coccia, F.; Testa, M.; Guarisco, G.; Di Cristofano, C.; Silecchia, G.; Leonetti, F.; Gastaldelli, A.; Capoccia, D.

Hepatic farnesoid X receptor protein level and circulating fibroblast growth factor 19 concentration in children with NAFLD

2018 - LIVER INTERNATIONAL

Nobili, V; Alisi, A; Mosca, A; Della Corte, C; Veraldi, S; De Vito, R; DE STEFANIS, Claudia; D'Oria, V; Jahnel, J; Zohrer, E; Scorletti, E; Byrne, Cd

Nonalcoholic fatty liver disease in children

2018 - SEMINARS IN LIVER DISEASE

Mann, Jake P.; Valenti, Luca; Scorletti, Eleonora; Byrne, Christopher D.; Nobili, Valerio

Relationship between nonalcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents

2018 - LIVER INTERNATIONAL

Mosca, Antonella; Fintini, Danilo; Scorletti, Elenora; Cappa, Marco; Paone, Laura; Zicari, Anna Maria; Nobili, Valerio; Byrne, Christopher D

Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review

2018 - CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

Mann, Jp; Tang, Gy; Nobili, V; Armstrong, Mj

Development of hepatocellular cancer induced by long term low fat-high carbohydrate diet in a NAFLD/NASH mouse model

2017 - ONCOTARGET

Tessitore, Alessandra; Mastroiaco, Valentina; Vetuschi, Antonella; Sferra, Roberta; Pompili, Simona; Cicciarelli, Germana; Barnabei, Remo; Capece, Daria; Zazzeroni, Francesca; Capalbo, Carlo; Alesse, Edoardo

Two-hour postload glycemia is associated to an increased risk of NAFLD in healthy subjects with family history of type 2 diabetes: a case control study

2016 - ENDOCRINE

Pallotta, Nadia; Filardi, Tiziana; Carnovale, Anna; Nieddu, Luciano; Mariani, Paola; Vincoli, Giuseppina; Lenzi, Andrea; Morano, Susanna

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

2016 - GASTROENTEROLOGY

Mancina, Rm; Dongiovanni, P; Petta, S; Pingitore, P; Meroni, M; Rametta, R; BorÃ©n, J; Montalcini, T; Pujia, A; Wiklund, O; Hindy, G; Spagnuolo, R; Motta, Bm; Pipitone, Rm; CraxÃ¬, A; Fargion, S; Nobili, V; KÃ¤kelÃ¤, P; KÃ¤rjÃ¤, V; MÃ¤nnistÃ¶, V; PihlajamÃ¤ki, J; Reilly, Df; Castro-Perez, J; Kozlitina, J; Valenti, L; Romeo, S.

A "systems medicine" approach to the study of non-alcoholic fatty liver disease

2016 - DIGESTIVE AND LIVER DISEASE

Petta, S; Valenti, L; Bugianesi, E; Targher, G; Bellentani, S; Bonino, F; Nobili, V

Statin use and non-alcoholic steatohepatitis in at risk individuals

2015 - JOURNAL OF HEPATOLOGY

Dongiovanni, P; Petta, S; Mannisto, V; Mancina, Rm; Pipitone, R; Karja, V; Maggioni, M; Kakela, P; Wiklund, O; Mozzi, E; Grimaudo, S; Kaminska, D; Rametta, R; Craxi, A; Fargion, S; Nobili, V; Romeo, S; Pihlajamaki, J; Valenti, L.